<p>Definitive Healthcare（纳斯达克股票代码：DH - 获取免费报告）在周四更新了 2026 年第一季度的盈利指引。该公司提供的每股收益（EPS）指引为 0.030-0.030，而市场共识预期为 0.050。该公司发布的收入指引为 5400 万美元至 5600 万美元，而市场共识收入预期为 5720 万美元。Definitive Healthcare 还将其 2026 财年的指引更新为 0.140-0.170 EPS。</p>
<p>获取 <strong>Definitive Healthcare</strong> 的提醒：</p>
<h2>Definitive Healthcare 股票表现</h2>
<p>周四交易时段，纳斯达克 DH 的股价下跌 0.01 美元，报 1.40 美元。该公司股票交易量为 753,013 股，较其平均交易量 372,979 股有所增加。该公司的 50 日移动平均价格为 2.23 美元，200 日移动平均价格为 2.90 美元。Definitive Healthcare 的 1 年最低价为 1.36 美元，1 年最高价为 5.22 美元。该股票的市值为 1.9791 亿美元，市盈率为-0.84，贝塔值为 1.59。该公司的债务与股本比率为 0.41，流动比率为 1.60，速动比率为 1.60。</p>
<p>Definitive Healthcare（纳斯达克股票代码：DH - 获取免费报告）最后一次发布财报是在 2 月 26 日，周四。该公司报告的每股收益（EPS）为 0.06 美元，符合分析师的共识预期 0.06 美元。该季度的收入为 6153 万美元，而分析师预期为 5957 万美元。Definitive Healthcare 的股本回报率为 3.30%，净利润率为-77.88%。Definitive Healthcare 将其 2026 财年的指引设定为 0.140-0.170 EPS，2026 年第一季度的指引为 0.030-0.030 EPS。平均而言，卖方分析师预计 Definitive Healthcare 在当前财年将发布 0.16 的每股收益。</p>
<h2>分析师设定新目标价</h2>
<p>一些股票分析师最近对该股票发布了报告。Weiss Ratings 在 1 月 21 日的研究报告中重申了对 Definitive Healthcare 股票的 “卖出（d-）” 评级。William Blair 在 11 月 6 日的研究报告中将 Definitive Healthcare 的股票评级上调至 “强力买入”。Wall Street Zen 在 12 月 28 日的研究报告中将 Definitive Healthcare 的股票评级从 “强力买入” 下调至 “买入”。Barclays 在 12 月 8 日的研究报告中将 Definitive Healthcare 的目标价从 3.00 美元下调至 2.75 美元，并对该公司设定了 “减持” 评级。最后，摩根士丹利在 12 月 18 日的研究报告中重申了 “表现不佳” 评级，并将 Definitive Healthcare 的目标价设定为 3.50 美元。一位股票研究分析师对该股票给予了强力买入评级，一位给予了买入评级，三位给予了持有评级，三位给予了卖出评级。根据 MarketBeat，该股票目前的共识评级为 “持有”，共识目标价为 3.94 美元。</p>
<p><strong>查看我们关于 DH 的最新研究报告</strong></p>
<h2>机构资金流入和流出</h2>
<p>一些对冲基金和其他机构投资者最近增加或减少了对该公司的投资。Raymond James Financial Inc.在第二季度收购了 Definitive Healthcare 的新股份，价值约 32,000 美元。Schonfeld Strategic Advisors LLC 在第四季度购买了 Definitive Healthcare 的新股份，价值约 35,000 美元。Bayesian Capital Management LP 在第二季度购买了 Definitive Healthcare 的新股份，价值约 55,000 美元。Prelude Capital Management LLC 在第三季度收购了 Definitive Healthcare 的新股份，价值 64,000 美元。最后，ExodusPoint Capital Management LP 在第四季度收购了 Definitive Healthcare 的新股份，价值 47,000 美元。机构投资者持有该公司 98.67% 的股票。</p>
<h2>关于 Definitive Healthcare</h2>
<p>（获取免费报告）</p>
<p>Definitive Healthcare（纳斯达克：DH）是医疗服务提供者、组织及其治疗患者的专业人员的情报和分析的领先提供商。通过其基于云的平台，该公司从多个来源聚合数据，包括索赔、政府注册、商业备案和专有研究，以提供医疗保健领域的统一视图。其解决方案使生命科学公司、医疗服务提供者、支付方和咨询公司能够识别市场机会，优化销售和营销工作，提高运营效率，并支持更好的患者结果。</p>
<p>该公司的旗舰产品是一个基于订阅的数据平台，提供关于医生、医院、健康系统和后期护理设施的详细资料。</p>
<h2>另见</h2>
<ul>
<li>我们更看好的五只股票比 Definitive Healthcare 更好</li>
<li>阅读此文或将永远后悔</li>
<li>解锁：埃隆·马斯克的下一个大 IPO</li>
<li>这让我感到愤怒</li>
<li>“特朗普效应” 对超过 50,000 美元的 IRA 的影响</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Definitive Healthcare 吗？</h2>
<p>在考虑 Definitive Healthcare 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄向客户推荐在更广泛的市场注意到之前购买……而 Definitive Healthcare 并不在名单上。</p>
<p>虽然 Definitive Healthcare 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Definitive Healthcare (NASDAQ:DH) 更新了其 2026 年第一季度的盈利指引，预计每股收益为 0.030 美元，低于市场共识预期的 0.050 美元。收入指引设定在 5400 万至 5600 万美元之间，同样低于市场共识的 5720 万美元。该公司已将 2026 财年的每股收益指引调整为 0.140 至 0.170 美元。股票交易下跌至 1.40 美元，市值为 1.9791 亿美元，分析师的共识评级为 “持有”</p>

<p>Definitive Healthcare (NASDAQ:DH - Get Free Report) updated its first quarter 2026 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.030-0.030 for the period, compared to the consensus estimate of 0.050. The company issued revenue guidance of $54.0 million-$56.0 million, compared to the consensus revenue estimate of $57.2 million. Definitive Healthcare also updated its FY 2026 guidance to 0.140-0.170 EPS.</p>
<div class="lb-trans"><p>Definitive Healthcare（纳斯达克股票代码：DH - 获取免费报告）在周四更新了 2026 年第一季度的盈利指引。该公司提供的每股收益（EPS）指引为 0.030-0.030，而市场共识预期为 0.050。该公司发布的收入指引为 5400 万美元至 5600 万美元，而市场共识收入预期为 5720 万美元。Definitive Healthcare 还将其 2026 财年的指引更新为 0.140-0.170 EPS。</p>
</div><p>Get <strong>Definitive Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Definitive Healthcare</strong> 的提醒：</p>
</div><h2>Definitive Healthcare Stock Performance</h2>
<div class="lb-trans"><h2>Definitive Healthcare 股票表现</h2>
</div><p>Shares of NASDAQ DH traded down $0.01 during trading hours on Thursday, hitting $1.40. 753,013 shares of the company's stock were exchanged, compared to its average volume of 372,979. The company's 50-day moving average price is $2.23 and its 200-day moving average price is $2.90. Definitive Healthcare has a 1-year low of $1.36 and a 1-year high of $5.22. The stock has a market capitalization of $197.91 million, a price-to-earnings ratio of -0.84 and a beta of 1.59. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.60 and a quick ratio of 1.60.</p>
<div class="lb-trans"><p>周四交易时段，纳斯达克 DH 的股价下跌 0.01 美元，报 1.40 美元。该公司股票交易量为 753,013 股，较其平均交易量 372,979 股有所增加。该公司的 50 日移动平均价格为 2.23 美元，200 日移动平均价格为 2.90 美元。Definitive Healthcare 的 1 年最低价为 1.36 美元，1 年最高价为 5.22 美元。该股票的市值为 1.9791 亿美元，市盈率为-0.84，贝塔值为 1.59。该公司的债务与股本比率为 0.41，流动比率为 1.60，速动比率为 1.60。</p>
</div><p>Definitive Healthcare (NASDAQ:DH - Get Free Report) last released its earnings results on Thursday, February 26th. The company reported $0.06 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.06. The firm had revenue of $61.53 million for the quarter, compared to analyst estimates of $59.57 million. Definitive Healthcare had a positive return on equity of 3.30% and a negative net margin of 77.88%.Definitive Healthcare has set its FY 2026 guidance at 0.140-0.170 EPS and its Q1 2026 guidance at 0.030-0.030 EPS. On average, sell-side analysts expect that Definitive Healthcare will post 0.16 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Definitive Healthcare（纳斯达克股票代码：DH - 获取免费报告）最后一次发布财报是在 2 月 26 日，周四。该公司报告的每股收益（EPS）为 0.06 美元，符合分析师的共识预期 0.06 美元。该季度的收入为 6153 万美元，而分析师预期为 5957 万美元。Definitive Healthcare 的股本回报率为 3.30%，净利润率为-77.88%。Definitive Healthcare 将其 2026 财年的指引设定为 0.140-0.170 EPS，2026 年第一季度的指引为 0.030-0.030 EPS。平均而言，卖方分析师预计 Definitive Healthcare 在当前财年将发布 0.16 的每股收益。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>A number of equities analysts recently issued reports on the stock. Weiss Ratings reaffirmed a &#34;sell (d-)&#34; rating on shares of Definitive Healthcare in a research report on Wednesday, January 21st. William Blair upgraded shares of Definitive Healthcare to a &#34;strong-buy&#34; rating in a research report on Thursday, November 6th. Wall Street Zen lowered shares of Definitive Healthcare from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a research report on Sunday, December 28th. Barclays reduced their target price on shares of Definitive Healthcare from $3.00 to $2.75 and set an &#34;underweight&#34; rating for the company in a research note on Monday, December 8th. Finally, Morgan Stanley restated an &#34;underperform&#34; rating and set a $3.50 price target on shares of Definitive Healthcare in a research note on Thursday, December 18th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, three have given a Hold rating and three have assigned a Sell rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of &#34;Hold&#34; and a consensus target price of $3.94.</p>
<div class="lb-trans"><p>一些股票分析师最近对该股票发布了报告。Weiss Ratings 在 1 月 21 日的研究报告中重申了对 Definitive Healthcare 股票的 “卖出（d-）” 评级。William Blair 在 11 月 6 日的研究报告中将 Definitive Healthcare 的股票评级上调至 “强力买入”。Wall Street Zen 在 12 月 28 日的研究报告中将 Definitive Healthcare 的股票评级从 “强力买入” 下调至 “买入”。Barclays 在 12 月 8 日的研究报告中将 Definitive Healthcare 的目标价从 3.00 美元下调至 2.75 美元，并对该公司设定了 “减持” 评级。最后，摩根士丹利在 12 月 18 日的研究报告中重申了 “表现不佳” 评级，并将 Definitive Healthcare 的目标价设定为 3.50 美元。一位股票研究分析师对该股票给予了强力买入评级，一位给予了买入评级，三位给予了持有评级，三位给予了卖出评级。根据 MarketBeat，该股票目前的共识评级为 “持有”，共识目标价为 3.94 美元。</p>
</div><p><strong>Check Out Our Latest Research Report on DH</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 DH 的最新研究报告</strong></p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Raymond James Financial Inc. acquired a new stake in Definitive Healthcare during the second quarter valued at approximately $32,000. Schonfeld Strategic Advisors LLC bought a new position in shares of Definitive Healthcare during the 4th quarter worth approximately $35,000. Bayesian Capital Management LP bought a new position in shares of Definitive Healthcare during the 2nd quarter worth approximately $55,000. Prelude Capital Management LLC acquired a new stake in Definitive Healthcare in the 3rd quarter valued at $64,000. Finally, ExodusPoint Capital Management LP bought a new stake in Definitive Healthcare in the fourth quarter valued at $47,000. Institutional investors own 98.67% of the company's stock.</p>
<div class="lb-trans"><p>一些对冲基金和其他机构投资者最近增加或减少了对该公司的投资。Raymond James Financial Inc.在第二季度收购了 Definitive Healthcare 的新股份，价值约 32,000 美元。Schonfeld Strategic Advisors LLC 在第四季度购买了 Definitive Healthcare 的新股份，价值约 35,000 美元。Bayesian Capital Management LP 在第二季度购买了 Definitive Healthcare 的新股份，价值约 55,000 美元。Prelude Capital Management LLC 在第三季度收购了 Definitive Healthcare 的新股份，价值 64,000 美元。最后，ExodusPoint Capital Management LP 在第四季度收购了 Definitive Healthcare 的新股份，价值 47,000 美元。机构投资者持有该公司 98.67% 的股票。</p>
</div><h2>About Definitive Healthcare</h2>
<div class="lb-trans"><h2>关于 Definitive Healthcare</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Definitive Healthcare NASDAQ: DH is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.</p>
<div class="lb-trans"><p>Definitive Healthcare（纳斯达克：DH）是医疗服务提供者、组织及其治疗患者的专业人员的情报和分析的领先提供商。通过其基于云的平台，该公司从多个来源聚合数据，包括索赔、政府注册、商业备案和专有研究，以提供医疗保健领域的统一视图。其解决方案使生命科学公司、医疗服务提供者、支付方和咨询公司能够识别市场机会，优化销售和营销工作，提高运营效率，并支持更好的患者结果。</p>
</div><p>The company's flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.</p>
<div class="lb-trans"><p>该公司的旗舰产品是一个基于订阅的数据平台，提供关于医生、医院、健康系统和后期护理设施的详细资料。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Definitive Healthcare</li>
<li>Read this or regret it forever</li>
<li>Unlocked: Elon Musk’s Next Big IPO</li>
<li>This makes me furious</li>
<li>The &#34;Trump Effect&#34; on IRAs over $50k</li>
<li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Definitive Healthcare 更好</li>
<li>阅读此文或将永远后悔</li>
<li>解锁：埃隆·马斯克的下一个大 IPO</li>
<li>这让我感到愤怒</li>
<li>“特朗普效应” 对超过 50,000 美元的 IRA 的影响</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Definitive Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Definitive Healthcare 吗？</h2>
</div><p>Before you consider Definitive Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Definitive Healthcare 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Definitive Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄向客户推荐在更广泛的市场注意到之前购买……而 Definitive Healthcare 并不在名单上。</p>
</div><p>While Definitive Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Definitive Healthcare 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Definitive Healthcare（纳斯达克股票代码：DH）发布 2026 年第一季度业绩指引